You are here: Industry Insights > SARS

News List

Researchers discover new antibody that reduces severity of COVID-19 infection ExpressPharma
November 05, 2021
Scientists have identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as SARS.
Study Gives Hope for 'Dream' Vaccine Against All COVID Variants drugs
August 24, 2021
A multi-purpose vaccine that would protect humans against any future COVID-19 variants could one day be possible, a new study suggests.
Sen-Jam Pharmaceutical Partners With Duke-NUS Medical School for a Phase 2 Trial for a New COVID 19 Treatment americanpharmaceuticalreview
August 13, 2021
Sen-Jam, a life-science startup led by Registered Pharmacist Jacqueline Iversen, has partnered with researcher Ashley St. John PhD of the Duke-NUS Medical School in Singapore, to trial a novel combination of two proven drug molecules that may work ...
Search for COVID-19 drugs boosted by SARS discovery worldpharmanews
August 28, 2020
An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19.
Moderna COVID-19 vaccine appears to clear safety hurdle in mouse study expresspharma
June 16, 2020
Prior studies on a vaccine for SARS - a close cousin to the new virus that causes COVID-19 - suggests vaccines against this type of virus might have the unintended effect of causing more severe disease when the vaccinated person is later exposed to the ..
Study finds novel coronavirus can remain stable for days pharmaceutical-technology
March 19, 2020
A study led by the US National Institutes of Health found that the novel coronavirus that causes Covid-19 can be viable in air for several hours and on surfaces for days.
New findings show SARS drugs can help treat Covid-19 pharmaceutical-technology
March 04, 2020
Researchers in the US have mapped a SARS-CoV-2 protein, which could help use drugs developed to treat SARS coronavirus as effective treatments for the new Covid-19 disease.
Strong efficacy but serious side-effects with Spark's haemophilia drug drop shares by 30% pharmafile
August 09, 2018
Spark Therapeutics has been left reeling after it revealed new data on its haemophilia A treatment, which, while promising in efficacy, left investors disappointed and share price plummeting.